Companies

Peregrine Pharmaceuticals

NASDAQ: PPHM
$4.22
â–² $0.03 (+0.72%) today
Markets closed · 3:41am ET
Today · % change

PPHM Coverage

12:25pm ET
Health and Healthcare

Why Peregrine Absolutely Tanked

Peregine Pharmaceuticals has announced that it is discontinuing its Phase 3 Sunrise trial of bavituximab in patients with previously treated locally advanced or metastatic non-squamous non-small cell lung cancer.

Chris Lange
7:35am ET
Health and Healthcare

Peregrine Move Looks Sustainable, at Least for Now

Peregrine Pharmaceuticals may be on the verge of something big with its anticancer drugs. The shares soared almost 50% on Wednesday. It is working on developing drugs that can train the body's…

cgblaine22
4:06pm ET
Investing

24/7 Wall St. Closing Bell — February 13, 2013: Markets Get No Direction Today (CLWR, GE, GRPN, CLF, PM, RATE, BWLD, CLWR, RAX, CMCSA, DF, DE, TOT, AMAT, CAR, CTL, CSCO, CLD, IPI, KGC, MET, NTAP, PXD, TRIP, Z, ANR, ABX, DTV, PEP, RSOL, BBRY, PPHM)

U.S. equity markets opened higher this morning following a closely watched report on U.S. retail sales came in about as expected (more coverage here). U.S. business inventories rose less than expected in…

Paul Ausick
11:27am ET
Investing

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.42%, the Nasdaq down 0.18% and the S&P 500 down 0.43%. Today’s winners include a pharmaceutical providing a positive…

247sam
10:42am ET
Investing

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market rose Thursday early in trading, with the Dow Jones Industrial Average up 0.12%, the Nasdaq up 0.46% and the S&P 500 up 0.27%. Trading volumes were light, and…

247sam
10:30am ET
Investing

Today’s Market Winners and Losers

The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.12%, the Nasdaq down 0.76% and the S&P 500 down 0.42%. Today’s only winner is a pharmaceutical company that…

247sam
12:06pm ET
Health and Healthcare

No News is Good News — Peregrine Pharma

Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data reported on the company’s Phase II trial of its lung-cancer drug bavituximab.…

Paul Ausick